Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
Supramolecular assemblies of quaternary ammonium cations and halide anions in the gas phase: ESMS-FTICR data and computer modelling.

Chemistry (Weinheim an der Bergstrasse, Germany)

Hasselgren C, Fisher K, Jagner S, Dance I.
PMID: 11073236
Chemistry. 2000 Oct 16;6(20):3671-8. doi: 10.1002/1521-3765(20001016)6:20<3671::aid-chem3671>3.0.co;2-a.

Supramolecular aggregates of tetraalkylammonium halides (R4NX) are formed by electrospray out of acetonitrile solution. Mass spectrometry reveals 88 charged aggregates for R= Me, Et, Bu; X= Br, I, ranging up to [(Bu4N)39Br42]3- in size. With the objective of improving...

Cite
Hasselgren C, Fisher K, Jagner S, et al. Supramolecular assemblies of quaternary ammonium cations and halide anions in the gas phase: ESMS-FTICR data and computer modelling. Chemistry. 2000;6(20):3671-8doi: 10.1002/1521-3765(20001016)6:20<3671::aid-chem3671>3.0.co;2-a.
Hasselgren, C., Fisher, K., Jagner, S., & Dance, I. (2000). Supramolecular assemblies of quaternary ammonium cations and halide anions in the gas phase: ESMS-FTICR data and computer modelling. Chemistry (Weinheim an der Bergstrasse, Germany), 6(20), 3671-8. https://doi.org/10.1002/1521-3765(20001016)6:20<3671::aid-chem3671>3.0.co;2-a
Hasselgren, et al. "Supramolecular assemblies of quaternary ammonium cations and halide anions in the gas phase: ESMS-FTICR data and computer modelling." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 6,20 (2000): 3671-8. doi: https://doi.org/10.1002/1521-3765(20001016)6:20<3671::aid-chem3671>3.0.co;2-a
Hasselgren C, Fisher K, Jagner S, Dance I. Supramolecular assemblies of quaternary ammonium cations and halide anions in the gas phase: ESMS-FTICR data and computer modelling. Chemistry. 2000 Oct 16;6(20):3671-8. doi: 10.1002/1521-3765(20001016)6:20<3671::aid-chem3671>3.0.co;2-a. PMID: 11073236.
Copy Download .nbib Format: NLM
Three-coordinate [Cu(II)X(3)](-) (X=Cl, Br), trapped in a molecular crystal.

Chemistry (Weinheim an der Bergstrasse, Germany)

Hasselgren C, Jagner S, Dance I.
PMID: 11921210
Chemistry. 2002 Mar 15;8(6):1269-78. doi: 10.1002/1521-3765(20020315)8:6<1269::aid-chem1269>3.0.co;2-9.

Mixtures of [Ph(3)PNPPh(3)](+)Cl(-) with CuBr(2) (or CuBr(2)+CuCl(2)) in ethanol/dichloromethane yield crystals containing three-coordinate copper(II) with mixed chloride and bromide ligands, namely [Ph(3)PNPPh(3)](+)[CuCl(0.9)Br(2.1)](-) (1) and [Ph(3)PNPPh(3)](+)[CuCl(2.4)Br(0.6)](-) (2). The trigonal-planar coordination of copper(II) is angularly distorted but unambiguous, as there is...

Cite
Hasselgren C, Jagner S, Dance I. Three-coordinate [Cu(II)X(3)](-) (X=Cl, Br), trapped in a molecular crystal. Chemistry. 2002;8(6):1269-78doi: 10.1002/1521-3765(20020315)8:6<1269::aid-chem1269>3.0.co;2-9.
Hasselgren, C., Jagner, S., & Dance, I. (2002). Three-coordinate [Cu(II)X(3)](-) (X=Cl, Br), trapped in a molecular crystal. Chemistry (Weinheim an der Bergstrasse, Germany), 8(6), 1269-78. https://doi.org/10.1002/1521-3765(20020315)8:6<1269::aid-chem1269>3.0.co;2-9
Hasselgren, Catrin, et al. "Three-coordinate [Cu(II)X(3)](-) (X=Cl, Br), trapped in a molecular crystal." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 8,6 (2002): 1269-78. doi: https://doi.org/10.1002/1521-3765(20020315)8:6<1269::aid-chem1269>3.0.co;2-9
Hasselgren C, Jagner S, Dance I. Three-coordinate [Cu(II)X(3)](-) (X=Cl, Br), trapped in a molecular crystal. Chemistry. 2002 Mar 15;8(6):1269-78. doi: 10.1002/1521-3765(20020315)8:6<1269::aid-chem1269>3.0.co;2-9. PMID: 11921210.
Copy Download .nbib Format: NLM
Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms.

Mediators of inflammation

Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE.
PMID: 18475468
Mediators Inflamm. 1992;1(4):247-50. doi: 10.1155/S0962935192000371.

The purpose of this study was to test the hypothesis that muscle proteolysis induced by TNF or IL-1 is mediated by glucocorticoids. Rats were treated with 300 mug kg(-1) of recombinant human preparations of IL-1alpha (rIL-1alpha) or TNFalpha (rTNFalpha)...

Cite
Zamir O, Hasselgren PO, Higashiguchi T, et al. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm. 1992;1(4):247-50doi: 10.1155/S0962935192000371.
Zamir, O., Hasselgren, P. O., Higashiguchi, T., Frederick, J. A., & Fischer, J. E. (1992). Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators of inflammation, 1(4), 247-50. https://doi.org/10.1155/S0962935192000371
Zamir, O, et al. "Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms." Mediators of inflammation vol. 1,4 (1992): 247-50. doi: https://doi.org/10.1155/S0962935192000371
Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm. 1992;1(4):247-50. doi: 10.1155/S0962935192000371. PMID: 18475468; PMCID: PMC2365344.
Copy Download .nbib Format: NLM
Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats.

Journal of cachexia, sarcopenia and muscle

Alamdari N, Hasselgren PO.
PMID: 22450731
J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):71-2. doi: 10.1007/s13539-012-0057-7. Epub 2012 Feb 23.

No abstract available.

Cite
Alamdari N, Hasselgren PO. Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats. J Cachexia Sarcopenia Muscle. 2012;3(1):71-2doi: 10.1007/s13539-012-0057-7.
Alamdari, N., & Hasselgren, P. O. (2012). Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats. Journal of cachexia, sarcopenia and muscle, 3(1), 71-2. https://doi.org/10.1007/s13539-012-0057-7
Alamdari, Nima, and Hasselgren, Per-Olof. "Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats." Journal of cachexia, sarcopenia and muscle vol. 3,1 (2012): 71-2. doi: https://doi.org/10.1007/s13539-012-0057-7
Alamdari N, Hasselgren PO. Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats. J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):71-2. doi: 10.1007/s13539-012-0057-7. Epub 2012 Feb 23. PMID: 22450731; PMCID: PMC3302989.
Copy Download .nbib Format: NLM
Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD.

European clinical respiratory journal

Stegberg M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.
PMID: 29321831
Eur Clin Respir J. 2018 Jan 04;5(1):1421389. doi: 10.1080/20018525.2017.1421389. eCollection 2018.

No abstract available.

Cite
Stegberg M, Hasselgren M, Montgomery S, et al. Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD. Eur Clin Respir J. 2018;5(1):1421389doi: 10.1080/20018525.2017.1421389.
Stegberg, M., Hasselgren, M., Montgomery, S., Lisspers, K., Ställberg, B., Janson, C., & Sundh, J. (2018). Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD. European clinical respiratory journal, 5(1), 1421389. https://doi.org/10.1080/20018525.2017.1421389
Stegberg, Marcus, et al. "Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD." European clinical respiratory journal vol. 5,1 (2018): 1421389. doi: https://doi.org/10.1080/20018525.2017.1421389
Stegberg M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J. Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD. Eur Clin Respir J. 2018 Jan 04;5(1):1421389. doi: 10.1080/20018525.2017.1421389. eCollection 2018. PMID: 29321831; PMCID: PMC5757235.
Copy Download .nbib Format: NLM
Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy".

Annals of surgery

Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P.
PMID: 32590545
Ann Surg. 2021 Dec 01;274(6):e750-e751. doi: 10.1097/SLA.0000000000004014.

No abstract available.

Cite
Hasselgren K, Røsok BI, Larsen PN, et al. Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy". Ann Surg. 2021;274(6):e750-e751doi: 10.1097/SLA.0000000000004014.
Hasselgren, K., Røsok, B. I., Larsen, P. N., Sparrelid, E., Lindell, G., Schultz, N. A., Bjørnbeth, B. A., Isaksson, B., Larsson, A. L., Rizell, M., Björnsson, B., & Sandström, P. (2021). Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy". Annals of surgery, 274(6), e750-e751. https://doi.org/10.1097/SLA.0000000000004014
Hasselgren, Kristina, et al. "Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy"." Annals of surgery vol. 274,6 (2021): e750-e751. doi: https://doi.org/10.1097/SLA.0000000000004014
Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P. Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy". Ann Surg. 2021 Dec 01;274(6):e750-e751. doi: 10.1097/SLA.0000000000004014. PMID: 32590545.
Copy Download .nbib Format: NLM
A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia.

Leukemia research

Nørskov KH, Fridthjof K, Kampmann P, Dünweber A, Andersen CL, Renaberg T, Schöllkopf C, Ahmad SA, Schou K, Jensen CF, Møller P, Lundholm BW, Marcher C, Jepsen L, Ørntoft AK, Ommen HB, Andersen L, Behrentzs A, Hasselgren CF, Severinsen M, Grand MK, Jarden M, Møller T, Kjeldsen L.
PMID: 34839055
Leuk Res. 2021 Nov 22;112:106756. doi: 10.1016/j.leukres.2021.106756. Epub 2021 Nov 22.

Technological advances have made it possible to offer home-based chemotherapy to patients without health care professionals being present. Prior studies on effects of home-based treatment lack inclusion of patients with hematologic malignancies. We present data from a multicenter single-arm...

Cite
Nørskov KH, Fridthjof K, Kampmann P, et al. A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia. Leuk Res. 2021;112:106756doi: 10.1016/j.leukres.2021.106756.
Nørskov, K. H., Fridthjof, K., Kampmann, P., Dünweber, A., Andersen, C. L., Renaberg, T., Schöllkopf, C., Ahmad, S. A., Schou, K., Jensen, C. F., Møller, P., Lundholm, B. W., Marcher, C., Jepsen, L., Ørntoft, A. K., Ommen, H. B., Andersen, L., Behrentzs, A., Hasselgren, C. F., Severinsen, M., Grand, M. K., Jarden, M., Møller, T., & Kjeldsen, L. (2021). A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia. Leukemia research, 112106756. https://doi.org/10.1016/j.leukres.2021.106756
Nørskov, Kristina Holmegaard, et al. "A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia." Leukemia research vol. 112 (2021): 106756. doi: https://doi.org/10.1016/j.leukres.2021.106756
Nørskov KH, Fridthjof K, Kampmann P, Dünweber A, Andersen CL, Renaberg T, Schöllkopf C, Ahmad SA, Schou K, Jensen CF, Møller P, Lundholm BW, Marcher C, Jepsen L, Ørntoft AK, Ommen HB, Andersen L, Behrentzs A, Hasselgren CF, Severinsen M, Grand MK, Jarden M, Møller T, Kjeldsen L. A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia. Leuk Res. 2021 Nov 22;112:106756. doi: 10.1016/j.leukres.2021.106756. Epub 2021 Nov 22. PMID: 34839055.
Copy Download .nbib Format: NLM
Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?.

The Journal of surgical research

Higgins S, James BC, Sacks B, Mowschenson P, Nishino M, Hasselgren PO.
PMID: 34298210
J Surg Res. 2021 Dec;268:112-118. doi: 10.1016/j.jss.2021.05.050. Epub 2021 Jul 20.

BACKGROUND: Although nearly half of thyroid nodules with Bethesda V cytology (suspicious for malignancy) may be benign or harbor low-grade neoplasms that can be sufficiently treated with lobectomy, many patients with Bethesda V cytology continue to be treated with...

Cite
Higgins S, James BC, Sacks B, et al. Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?. J Surg Res. 2021;268:112-118doi: 10.1016/j.jss.2021.05.050.
Higgins, S., James, B. C., Sacks, B., Mowschenson, P., Nishino, M., & Hasselgren, P. O. (2021). Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?. The Journal of surgical research, 268112-118. https://doi.org/10.1016/j.jss.2021.05.050
Higgins, Sara, et al. "Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?." The Journal of surgical research vol. 268 (2021): 112-118. doi: https://doi.org/10.1016/j.jss.2021.05.050
Higgins S, James BC, Sacks B, Mowschenson P, Nishino M, Hasselgren PO. Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?. J Surg Res. 2021 Dec;268:112-118. doi: 10.1016/j.jss.2021.05.050. Epub 2021 Jul 20. PMID: 34298210.
Copy Download .nbib Format: NLM
How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility.

Hepatobiliary surgery and nutrition

Sparrelid E, Hasselgren K, Røsok BI, Larsen PN, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Björnsson B.
PMID: 33575285
Hepatobiliary Surg Nutr. 2021 Jan;10(1):1-8. doi: 10.21037/hbsn.2019.10.36.

BACKGROUND: The role of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in comparison to portal vein embolization (PVE) is debated. The aim of this study was to compare successful resection rates (RR) with upfront ALPPS...

Cite
Sparrelid E, Hasselgren K, Røsok BI, et al. How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility. Hepatobiliary Surg Nutr. 2021;10(1):1-8doi: 10.21037/hbsn.2019.10.36.
Sparrelid, E., Hasselgren, K., Røsok, B. I., Larsen, P. N., Schultz, N. A., Carling, U., Fallentin, E., Gilg, S., Sandström, P., Lindell, G., & Björnsson, B. (2021). How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility. Hepatobiliary surgery and nutrition, 10(1), 1-8. https://doi.org/10.21037/hbsn.2019.10.36
Sparrelid, Ernesto, et al. "How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility." Hepatobiliary surgery and nutrition vol. 10,1 (2021): 1-8. doi: https://doi.org/10.21037/hbsn.2019.10.36
Sparrelid E, Hasselgren K, Røsok BI, Larsen PN, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Björnsson B. How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility. Hepatobiliary Surg Nutr. 2021 Jan;10(1):1-8. doi: 10.21037/hbsn.2019.10.36. PMID: 33575285; PMCID: PMC7867725.
Copy Download .nbib Format: NLM
Identification of Altered Gene Expression in Skeletal Muscle during Sepsis Using Differential Display.

The Journal of surgical research

Tiao GM, Hudson K, Lieberman MA, Fischer JE, Hasselgren PO.
PMID: 8812617
J Surg Res. 1996 Jul 15;64(1):63-7.

Different aspects of muscle metabolism are altered during sepsis and there is evidence that some of these changes may be regulated at the gene level. Differential display is a recently described technique to identify genes whose expression has changed...

Cite
Tiao GM, Hudson K, Lieberman MA, et al. Identification of Altered Gene Expression in Skeletal Muscle during Sepsis Using Differential Display. J Surg Res. 1996;64(1):63-7
Tiao, G. M., Hudson, K., Lieberman, M. A., Fischer, J. E., & Hasselgren, P. O. (1996). Identification of Altered Gene Expression in Skeletal Muscle during Sepsis Using Differential Display. The Journal of surgical research, 64(1), 63-7.
Tiao, et al. "Identification of Altered Gene Expression in Skeletal Muscle during Sepsis Using Differential Display." The Journal of surgical research vol. 64,1 (1996): 63-7.
Tiao GM, Hudson K, Lieberman MA, Fischer JE, Hasselgren PO. Identification of Altered Gene Expression in Skeletal Muscle during Sepsis Using Differential Display. J Surg Res. 1996 Jul 15;64(1):63-7. PMID: 8812617.
Copy Download .nbib Format: NLM
Blockchain in healthcare and health sciences-A scoping review.

International journal of medical informatics

Hasselgren A, Kralevska K, Gligoroski D, Pedersen SA, Faxvaag A.
PMID: 31865055
Int J Med Inform. 2020 Feb;134:104040. doi: 10.1016/j.ijmedinf.2019.104040. Epub 2019 Dec 11.

BACKGROUND: Blockchain can be described as an immutable ledger, logging data entries in a decentralized manner. This new technology has been suggested to disrupt a wide range of data-driven domains, including the health domain.OBJECTIVE: The purpose of this study...

Cite
Hasselgren A, Kralevska K, Gligoroski D, et al. Blockchain in healthcare and health sciences-A scoping review. Int J Med Inform. 2019;134:104040doi: 10.1016/j.ijmedinf.2019.104040.
Hasselgren, A., Kralevska, K., Gligoroski, D., Pedersen, S. A., & Faxvaag, A. (2020). Blockchain in healthcare and health sciences-A scoping review. International journal of medical informatics, 134104040. https://doi.org/10.1016/j.ijmedinf.2019.104040
Hasselgren, Anton, et al. "Blockchain in healthcare and health sciences-A scoping review." International journal of medical informatics vol. 134 (2020): 104040. doi: https://doi.org/10.1016/j.ijmedinf.2019.104040
Hasselgren A, Kralevska K, Gligoroski D, Pedersen SA, Faxvaag A. Blockchain in healthcare and health sciences-A scoping review. Int J Med Inform. 2020 Feb;134:104040. doi: 10.1016/j.ijmedinf.2019.104040. Epub 2019 Dec 11. PMID: 31865055.
Copy Download .nbib Format: NLM
Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014.

European clinical respiratory journal

Sundh J, Åberg J, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C.
PMID: 29230274
Eur Clin Respir J. 2017 Dec 04;4(1):1409060. doi: 10.1080/20018525.2017.1409060. eCollection 2017.

No abstract available.

Cite
Sundh J, Åberg J, Hasselgren M, et al. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir J. 2017;4(1):1409060doi: 10.1080/20018525.2017.1409060.
Sundh, J., Åberg, J., Hasselgren, M., Montgomery, S., Ställberg, B., Lisspers, K., & Janson, C. (2017). Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. European clinical respiratory journal, 4(1), 1409060. https://doi.org/10.1080/20018525.2017.1409060
Sundh, Josefin, et al. "Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014." European clinical respiratory journal vol. 4,1 (2017): 1409060. doi: https://doi.org/10.1080/20018525.2017.1409060
Sundh J, Åberg J, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir J. 2017 Dec 04;4(1):1409060. doi: 10.1080/20018525.2017.1409060. eCollection 2017. PMID: 29230274; PMCID: PMC5717719.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries